CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street

1 week ago 12

Ashar Jawad

Sat, March 7, 2026 astatine 6:10 AM CST 2 min read

CRISPR Therapeutics AG (NASDAQ:CRSP) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026, with a involvement worth of implicit $551 cardinal arsenic of Q4 2025.

The gene-editing institution remains connected analysts’ radar and presently carries a Moderate Buy rating, with an mean stock terms upside of 17% arsenic of March 4.

Recent updates see Truist Financial expert Joon Lee reiterating the firm’s Buy standing connected the banal connected March 2, according to TipRanks.

Earlier connected February 17, Chardan Capital lifted its terms people connected CRISPR Therapeutics AG (NASDAQ:CRSP) to $76 from $74 and maintained a Buy rating. The accommodation followed the company’s concern update and the announcement of its fourth-quarter results connected February 12.

CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street

CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street

Jirsak/Shutterstock.com

According to TipRanks, Chardan expert Geulah Livshits highlighted the momentum successful the company’s siRNA therapies and vivo cardiovascular editing, on with advancement crossed aggregate objective and preclinical programs.

Following the Q4 report, TD Cowen besides lifted the terms people to $45 from $40 with a Hold rating. The steadfast noted beardown momentum successful CASGEVY, with quarterly gross of $54 cardinal and full-year gross of $116 million. Moreover, expert Tyler Van Buren said helium was keenly anticipating respective objective updates that are scheduled for the 2nd fractional of 2026.

CRISPR Therapeutics AG (NASDAQ:CRSP) is simply a cistron editing institution focused connected processing CRISPR/Cas9-based therapeutics to dainty genetically-defined diseases and technologist precocious cellular therapies.

While we admit the imaginable of CRSP arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 10 Best Magic Formula Stocks for 2026.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article